3D microfilter device for viable circulating tumor cell (CTC) enrichment from blood

被引:357
作者
Zheng, Siyang [1 ]
Lin, Henry K. [2 ]
Lu, Bo [3 ]
Williams, Anthony [4 ]
Datar, Ram [4 ]
Cote, Richard J. [4 ]
Tai, Yu-Chong [3 ]
机构
[1] Penn State Univ, Dept Bioengn, University Pk, PA 16802 USA
[2] Oak Ridge Natl Lab, BioSci Div, Oak Ridge, TN 37831 USA
[3] CALTECH, Dept Elect Engn, Pasadena, CA 91125 USA
[4] Univ Miami, Dept Pathol, Miami, FL 33136 USA
关键词
Circulating tumor cell; Microfilter; Parylene; METASTATIC BREAST-CANCER; POLYMERASE CHAIN-REACTION; PERIPHERAL-BLOOD; STEM-CELLS; SURVIVAL; THERAPY; SIZE; ENUMERATION; PROGRESSION; TECHNOLOGY;
D O I
10.1007/s10544-010-9485-3
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Detection of circulating tumor cells has emerged as a promising minimally invasive diagnostic and prognostic tool for patients with metastatic cancers. We report a novel three dimensional microfilter device that can enrich viable circulating tumor cells from blood. This device consists of two layers of parylene membrane with pores and gap precisely defined with photolithography. The positions of the pores are shifted between the top and bottom membranes. The bottom membrane supports captured cells and minimize the stress concentration on cell membrane and sustain cell viability during filtration. Viable cell capture on device was investigated with scanning electron microscopy, confocal microscopy, and immunofluorescent staining using model systems of cultured tumor cells spiked in blood or saline. The paper presents and validates this new 3D microfiltration concept for circulation tumor cell enrichment application. The device provides a highly valuable tool for assessing and characterizing viable enriched circulating tumor cells in both research and clinical settings.
引用
收藏
页码:203 / 213
页数:11
相关论文
共 58 条
[1]   Circulating tumor cells and bone marrow micrometastasis [J].
Alix-Panabieres, Catherine ;
Riethdorf, Sabine ;
Pantel, Klaus .
CLINICAL CANCER RESEARCH, 2008, 14 (16) :5013-5021
[2]   Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases [J].
Allard, WJ ;
Matera, J ;
Miller, MC ;
Repollet, M ;
Connelly, MC ;
Rao, C ;
Tibbe, AGJ ;
Uhr, JW ;
Terstappen, LWMM .
CLINICAL CANCER RESEARCH, 2004, 10 (20) :6897-6904
[3]  
[Anonymous], 2007, BIOL CANC
[4]  
[Anonymous], 2008, WORLD CANC REPORT
[5]  
Baker MK, 2003, CLIN CANCER RES, V9, P4865
[6]  
Benez A, 1999, J CLIN LAB ANAL, V13, P229, DOI 10.1002/(SICI)1098-2825(1999)13:5<229::AID-JCLA7>3.3.CO
[7]  
2-P
[8]   Circulating and disseminated tumor cells [J].
Braun, S ;
Naume, B .
JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (08) :1623-1626
[9]   Circulating tumor cells versus imaging - Predicting overall survival in metastatic breast cancer [J].
Budd, G. Thomas ;
Cristofanilli, Massimo ;
Ellis, Mathew J. ;
Stopeck, Allison ;
Borden, Ernest ;
Miller, M. Craig ;
Matera, Jeri ;
Repollet, Madeline ;
Doyle, Gerald V. ;
Terstappen, Leon W. M. M. ;
Hayes, Daniel F. .
CLINICAL CANCER RESEARCH, 2006, 12 (21) :6403-6409
[10]   Cell and protein compatibility of parylene-C surfaces [J].
Chang, Tracy Y. ;
Yadav, Vikramaditya G. ;
De Leo, Sarah ;
Mohedas, Agustin ;
Rajalingam, Birnal ;
Chen, Chia-Ling ;
Selvarasah, Selvapraba ;
Dokmeci, Mehmet R. ;
Khademhosseini, Ali .
LANGMUIR, 2007, 23 (23) :11718-11725